Dr. Dean Regier is a Senior Scientist at the BC Cancer Research Institute, Associate Professor in the School of Population and Public Health at the University of British Columbia (UBC), and Director of the Academy of Translational Medicine (ATM) in UBC’s Faculty of Medicine. An internationally recognized health economist specializing in translational medicine and regulatory science, he leads the Regulatory Science Lab (RSL), which advances learning healthcare systems and develops policies to accelerate access to safe, effective, and cost-effective care. His research emphasizes patient-oriented outcomes and AI-supported real-world evidence generation, and has been instrumental in advancing equitable access to genomic technologies for Canadians—particularly in precision oncology and rare diseases.
As Director of the ATM and RSL, Dr. Regier is leading the Academy’s evolution into a world-class hub for innovation in translational medicine and regulatory science. He is expanding networks and educational initiatives in AI, regulatory affairs, regulatory science, and health economics, with the goal of strengthening UBC’s and British Columbia’s life sciences ecosystem. Through collaboration across research institutes, centres, and programs, he aims to drive global progress in translational medicine.
Director for the Academy of Translational Medicine (ATM), Faculty of Medicine, University of British Columbia
Associate Professor at the School of Population and Public Health, Faculty of Medicine, University of British Columbia
BA (High Honors) in Economics, University of Saskatchewan, CANADA
MA in Economics, Carleton University, CANADA
PhD in Health Economics, University of Aberdeen, UK
Fulford Junior Research Fellow, Somerville College, University of Oxford
